Search Within

Joachim Yahalom

  1. "Craig Moskowitz"
Formats
  1. Meeting Abstract (47)
  2. Journal Article (40)
Groups
  1. Department of Medicine (87)
  2. Hematologic Malignancies, Division of (87)
  3. Radiation Oncology, Department of (87)
  4. Survivorship Research (87)
  5. Center for Hematologic Malignancies (71)
  6. Lymphoma (71)

More Groups

People
  1. Craig Moskowitz (87)
  2. Andrew Zelenetz (62)
  3. David Straus (37)
  4. Carol Portlock (34)
  5. Ariela Noy (32)
  6. Paul Hamlin (26)

More People

Years
  1. 2023 (1)
  2. 2021 (2)
  3. 2020 (2)
  4. 2019 (1)
  5. 2018 (4)
  6. 2017 (8)

More Years

Publications
  1. Blood (37)
  2. International Journal of Radiation Oncology, Biology, Physics (9)
  3. Journal of Clinical Oncology (8)
  4. British Journal of Haematology (7)
  5. Journal of the National Comprehensive Cancer Network (5)
  6. Haematologica (4)

More Publications

Publishers
  1. American Society of Hematology (38)
  2. Elsevier Inc. (11)
  3. American Society of Clinical Oncology (8)
  4. John Wiley & Sons (7)
  5. Harborside Press (5)
  6. Ferrata Storti Foundation (4)

More Publishers

Results (87)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Persistent gallium avidity after second-line chemotherapy in Hodgkin's disease (HD) and intermediate-grade non-hodgkin's lymphoma (IGL) does not predict outcome following autologous stem cell transplantation (ASCT)
    Meeting Abstract

    Donnelly, G. B.; Hedrick, E. E.; Kewalramani, T.; Satagopan, J. M.; Walits, J.; Yahalom, J.; Zelenetz, A. D.; Nimer, S. D.; Moskowitz, C. H.
    Blood (1999)

    Fulltext@MSK | Save
  • Ifosfamide, carboplatin, and etoposide: A highly effective cytoreduction and peripheral-blood progenitor-cell mobilization regimen for transplant- eligible patients with non-Hodgkin's lymphoma
    Journal Article

    Moskowitz, C. H.; Bertino, J. R.; Glassman, J. R.; Hedrick, E. E.; Hunte, S.; Coady-Lyons, N.; Agus, D. B.; Goy, A.; Jurcic, J.; Noy, A.; more...
    Journal of Clinical Oncology (1999)

    Fulltext@MSK | Save
  • The International Prognostic Index predicts for outcome following autologous stem cell transplantation in patients with relapsed and primary refractory intermediate-grade lymphoma
    Journal Article

    Moskowitz, C. H.; Nimer, S. D.; Glassman, J. R.; Portlock, C. S.; Yahalom, J.; Straus, D. J.; O'Brien, J. P.; Elkin, N.; Bertino, J. R.; Zelenetz, A. D.
    Bone Marrow Transplantation (1999)

    Fulltext@MSK | Save
  • Th use of stanford v overcomes poor prognostic features in patients with advanced stage Hodgkin's disease (HD)
    Meeting Abstract

    Moskowitz, C. H.; Yahalom, J.; Straus, D.; Portlock, C. S.; Goy, A.; O'Brien, J. P.; Zelenetz, A. D.
    Blood (1998)

    Fulltext@MSK | Save
  • Safety and efficacy of high dose therapy and peripheral blood progenitor cell transplantation (HDT/PBPCT) in patients with non-Hodgkin's lymphoma (NHL) over the age of 55 years
    Meeting Abstract

    Hedrick, E. E.; Nimer, S. D.; Zelenetz, A. D.; Childs, B.; Frank, R.; Malhotra, S.; Coady-Lyons, N.; Yahalom, J.; Moskowitz, C. H.
    Blood (1998)

    Fulltext@MSK | Save
  • Ifosfamide (I), carboplatin (C) and etoposide (E) (ICE) cytoreduction followed by high dose chemoradiotherapy and ASCT for refractory and relapsed Hodgkin's disease (HD): An intent to treat study
    Meeting Abstract

    Moskowitz, C. H.; Nimer, S. D.; Portlock, C. S.; Straus, D. J.; Pearse, R.; O'Brien, J. P.; Berger, M.; Gardner, S.; Trippett, T. M.; Zelenetz, A. D.; more...
    Blood (1997)

    Fulltext@MSK | Save
  • High dose therapy with autologous stem cell rescue in pediatric patients with refractory Hodgkin's disease
    Meeting Abstract

    Gardner, S.; Boulad, F.; Gillio, A.; Kernan, N.; O'Reilly, R.; Small, T.; Szabolcs, P.; Tan, C.; Ganshaw, L.; Van Syckle, K.; more...
    Blood (1996)

    Fulltext@MSK | Save